Noteworthy ETF Outflows: XLV, LLY, BIIB, ESRX
May 23, 2013
Symbols mentioned in this story: XLV, LLY, BIIB, ESRX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category
ETFs
from ETF Channel
There is no place like home for Victor King McElheny, a visiting scholar at MIT's School of Humanities, Arts and Sciences, and former director of the M.I.T Science Writing Program. At 70 years of age,... Read More
from Forbes Real Time
Video shows how those from the medical field bring patient care experience to pharmaceutical career Read More
from PR Newswire
Opportunity in Cyclical Stocks
May 17, 2013
Cheerleaders: Look Beyond Pharma For Jobs
May 16, 2013
from YCharts
Notable ETF Inflow Detected - VHT, JNJ, LLY, UNH
May 16, 2013
Symbols mentioned in this story: VHT, JNJ, LLY, UNH Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category
ETFs
from ETF Channel
category
Pharmaceuticals
,
Industrials
from Trefis
from PR Newswire
PreMarket Info Recap for May 14, 2013
May 14, 2013
Lilly Provides Update on CEO Dr. John Lechleiter
May 14, 2013
from PR Newswire
from Business Journals
Options Update for Eli Lilly &
May 13, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ... Read More
from AVAFIN
Eli Lilly (LLY) flat as product falls short
May 10, 2013
Eli Lilly and Company (NYSE: LLY) nicked higher 0.1% to $54.56 after the company announced its Enzastaurin Phase III Study had failed to meet Primary Endpoint in Diffuse Large B-Cell Lymphoma. Share... Read More
from BAYSTREET RSS FEED
“Marketing Without Innovation”: a Merck Story
May 10, 2013
from YCharts
Pharmaceutical company, Eli Lilly & Co. (LLY) reported that it will stop the development of Enzastaurin, which will result in a second quarter R&D charge. The company has been developing a drug called... Read More
from Dividend Daily
Benzinga's Top Pre-Market Losers
May 10, 2013
Eli Lilly's lymphoma drug fails in late-stage trial
May 10, 2013
May 10 (Reuters) - Eli Lilly and Co said it will stop developing its experimental cancer drug after a late-stage trial failed to show a statistically significant increase in patients' disease-free... Read More
category
companyNews
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
May 10, 2013
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
May 10, 2013
from PR Newswire
Pharma’s Failure: Drug Spending Finally Declines
May 09, 2013
from YCharts
Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check... Read More
from Dividend Daily
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here